3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Terminated
1
Sponsor Class
INDUSTRY
178
OTHER
171
NIH
13
NETWORK
3
OTHER_GOV
1
Study Type
Interventional
1
Sponsor
Cancer Type
Head & Neck
37
Other
2
Breast
2
Thoracic
1
Gastrointestinal
1
CNS
1
Conditions
Carcinoma, Non-Small-Cell Lung
89
Lung Neoplasms
78
Small Cell Lung Carcinoma
28
Adenocarcinoma of Lung
8
Mesothelioma, Malignant
6
Esophageal Neoplasms
6
Carcinoma, Hepatocellular
4
Adenocarcinoma
4
Stomach Neoplasms
3
Neoplasm Metastasis
3
NSCLC
3
Motor Activity
3
Mesothelioma
3
Meningeal Carcinomatosis
3
Carcinoma, Renal Cell
3
Breast Neoplasms
3
Uterine Cervical Neoplasms
2
Thymoma
2
Sarcopenia
2
Pancreatic Neoplasms
2
Neuroendocrine Tumors
2
Neoplasms
2
Melanoma
2
Lung Diseases
2
EGFR Positive Non-small Cell Lung Cancer
2
Disease
2
Colorectal Neoplasms
2
Weight Loss
1
Untreated Advanced Non-small Cell Lung Cancer
1
Unresectable Non-small Cell Lung Cancer
1
Interventions
Gefitinib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER_GOV
×
Head and Neck Neoplasms
×
Thoracic
×
Clear all
NCT01405846
2016-08-19
TIDAL1
Papworth Hospital NHS Foundation Trust
Phase 2
Terminated
32 enrolled